Browse by:
Latest Headlines

Sunovion encouraged by schizophrenia drug test

Marlborough drugmaker Sunovion Pharmaceuticals announced Thursday that clinical tests for its new drug to treat adolescents with schizophrenia is showing positive signs.

CardioFocus adds chief commercial officer

Marlborough medical device manufacturer CardioFocus, Inc. announced Thursday it added a new chief commercial officer and a vice president of U.S. sales.

Solect opening 7,000sf Holliston warehouse

Brad Kane |

Hopkinton commercial solar installer Solect Energy plans to open a Holliston warehouse by mid-2017.

Mass Pike electronic tolling starts tomorrow

Laura Finaldi |

Manual toll collection on Massachusetts highways will officially end Oct. 28 at 9:45 p.m., and drivers have been asked to plan accordingly.

Kopin posts $7.8M loss

Laura Finaldi |

Westborough wearable technology maker Kopin Corp. reported a third quarter loss of $7.8 million, or 12 cents per share, the company announced on Thursday.

Brazilian drug testing jumps Psychemedics profits 240%

Laura Finaldi |

Thanks to growth in the Brazilian market, employment drug testing company Psychemedics reported a 240-percent increase in net income over the same period last year.

Shareholders approve $126M Providence and Worcester Railroad merger

Laura Finaldi |

The acquisition of the Providence and Worcester Railroad Company by Genesee & Wyoming Inc. got the green light on Wednesday after it was approved by P&W shareholders.

A "major" pharma employer could fill Devens site

State House News Service |

A zoning change approved by voters in three communities will create a 40-acre site available for commercial use in Devens, a space that could serve as a future home for a pharmaceutical company.

Legal pot opponents take aim at stoned driving


Legalization of marijuana would result in greater dangers on Massachusetts roadways, where authorities are ill-equipped to even know whether drivers are intoxicated by the drug, opponents of Question...

Boston Scientific sales top $2.1B; earnings up 13%

Sam Bonacci |

Boston Scientific of Marlborough generated $2.1 billion in sales and $368 million in earnings in its third quarter, the company announced Wednesday.

Copyright 2016 New England Business Media